Atrial fibrillation in primary aldosteronism

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 4, 2009, Pages 190-194

  Watson, Timothy ^a   Karthikeyan, Vellore J ^a   Lip, Gregory Yh ^a   Beevers, D Gareth ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation; Primary aldosteronism

Indexed keywords

ALDOSTERONE; AMILORIDE; AMLODIPINE; ATENOLOL; ATENOLOL PLUS CHLORTALIDONE; BISOPROLOL; DOXAZOSIN; EPLERENONE; LISINOPRIL; METOPROLOL; NIFEDIPINE; POTASSIUM; SODIUM; SPIRONOLACTONE;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIZZINESS; ELECTROCARDIOGRAM; GYNECOMASTIA; HEADACHE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOKALEMIA; LUNG EDEMA; MALE; OPHTHALMOSCOPY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; RETINA HEMORRHAGE; SINUS RHYTHM; SODIUM BLOOD LEVEL;

ADULT; ALDOSTERONE; ATRIAL FIBRILLATION; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; HYPOKALEMIA; MALE; MIDDLE AGED; RENIN;

EID: 73349088765     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309342734     Document Type: Article

References (31)

1. Nadar S., Lip GY, Beevers DG Primary hyperaldosteronism. Ann Clin Biochem 2003 ; 40: 439-452.
2. Rossi GP, Bernini G., Caliumi C. et al., PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006 ; 48: 2293-2300.
3. Kaplan NM Is there an unrecognized epidemic of primary aldosteronism? Hypertension 2007 ; 50: 454-458.
4. Conn JW Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955 ; 45: 6-10.
5. Ferriss JB, Beevers DG, Brown JJ et al. Low-renin ("primary") hyperaldosteronism. Differential diagnosis and distinction of sub-groups within the syndrome. Am Heart J 1978 ; 95: 641-658.
6. Francis GS, Tang WH Should we consider aldosterone as the primary screening target for preventing cardiovascular events? J Am Coll Cardiol 2005 ; 45: 1249-1250.
7. Beevers DG, Brown JJ, Ferriss JB et al. Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism. Q J Med 1976 ; 45: 401-410.
8. Felmeden DC, Gearty JG, Dawkins DM, Beevers DG Hypertension due to a giant aldosterone-secreting adenoma. J Renin Angiotensin Aldosterone Syst 2001 ; 2: 43-44.
9. Porodko M., Auer J., Eber B. Connĝ€™s syndrome and atrial fibrillation. Lancet 2001 ; 357: 1293-1294.
10. Abdo A., Bebb RA, Wilkins GE Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism. Can J Cardiol 1999 ; 15: 347-348.
11. Milliez P., Girerd X., Plouin PF, Blacher J., Safar ME, Mourad JJ Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005 ; 45: 1243-1248.
12. Brunner HR, Laragh JH, Baer L. et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972 ; 286: 441-449.
13. Stowasser M. New perspectives on the role of aldosterone excess in cardiovascular disease. Clin Exp Pharmacol Physiol 2001 ; 28: 783-791.
14. Freele EM, Connel JM Mechanisms of hypertension: the expanding role of aldosterone. J Am Soc Nephrol 2004 ; 15: 1993-2001.
15. Pitt B., Zannad F., Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999 ; 341: 709-717.
16. Pitt B., Remme W., Zannad F. et al., Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003 ; 348: 1309-1321.
17. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension 1995 ; 25: 1155-1160.
18. Mattioli AV, Bonatti S., Monopoli D., Zennaro M., Mattioli G. Left atrial remodelling after short duration atrial fibrillation in hypertrophic hearts. Heart 2005 ; 91: 91-92.
19. Dahlof B., Devereux RB, Kjeldsen SE et al., LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 ; 359: 995-1003. (Pubitemid 34286536)
20. Franklin SS, Wachtell K., Papademetriou V. et al. Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE sub study. Hypertension 2005 ; 46: 492-499.
21. Freestone B., Beevers DG, Lip GYH. The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target? J Hum Hypertens 2004 ; 18: 461-465.
22. Healey JS, Baranchuk A., Crystal E. et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005 ; 45: 1832-1839.
23. Wahr JA, Parks R., Boisvert D. et al. Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Perioperative Ischemia Research Group. JAMA 1999 ; 281: 2203-2210.
24. Emara MK, Saadet AM Transient atrial fibrillation in hypertensive patients with thiazide induced hypokalemia. Postgrad Med J 1986 ; 62: 1125-1127.
25. Oakley C. Genesis of arrhythmias in the failing heart and therapeutic implications. Am J Cardiol 1991 ; 67: 26C - 8C.
26. Korzets A., Ori Y., Herman M. Serum potassium levels and atrial fibrillation in haemodialysis patients. Nephrol Dial Transplant 2001 ; 16: 1090.
27. Lijnen P., Petrov V. Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol 2000 ; 32: 865-879.
28. Stumpf WE Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, glucoand mineralcorticoids, and soltriol [vitamin D] on central nervous regulatory and peripheral tissues. Experientia 1990 ; 46: 13-25.
29. Campbell SE, Diaz-Arias AA, Weber KT Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1992 ; 1: 149-156.
30. Shirani J., Alaeddini J. Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography. Cardiovasc Pathol 2000 ; 9: 95-101.
31. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997 ; 96: 1180-1184.